Mili Ramani

ORCID: 0009-0003-6714-691X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pancreatic and Hepatic Oncology Research
  • Caveolin-1 and cellular processes
  • Ferroptosis and cancer prognosis
  • RNA modifications and cancer
  • AI in cancer detection
  • Blood Coagulation and Thrombosis Mechanisms
  • Cancer Cells and Metastasis
  • Epigenetics and DNA Methylation
  • Cell Adhesion Molecules Research
  • Hemophilia Treatment and Research
  • Immune Response and Inflammation
  • Synthesis and Characterization of Heterocyclic Compounds
  • Cancer Immunotherapy and Biomarkers
  • RNA Research and Splicing
  • Blood properties and coagulation
  • Macrophage Migration Inhibitory Factor
  • Phagocytosis and Immune Regulation
  • Protease and Inhibitor Mechanisms
  • Single-cell and spatial transcriptomics
  • Cancer Genomics and Diagnostics
  • Cancer-related gene regulation

Johns Hopkins University
2024-2025

The University of Texas at Austin
2025

Johns Hopkins Medicine
2024-2025

Bloomberg (United States)
2024

University of Baltimore
2024

Sidney Kimmel Comprehensive Cancer Center
2024

Inserm
1993-1995

Abstract Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy characterized by immunosuppressive tumor microenvironment enriched with cancer-associated fibroblasts (CAF). This study used a convergence approach to identify cell and CAF interactions through the integration of single-cell data from human tumors organoid coculture experiments. Analysis comprehensive atlas PDAC RNA sequencing indicated that density associated increased inflammation epithelial–mesenchymal transition...

10.1158/0008-5472.can-23-1660 article EN Cancer Research 2024-04-08

Pro1 is a critical catalytic residue in the characterized activities of tautomerase superfamily (TSF) members. Only handful members (∼346) lack sequence similarity network (SSN) that consists over 11,000 Most (294 members) are malonate semialdehyde decarboxylase (MSAD)-like subgroup, but ones thus far have little or no MSAD activity. Moreover, there to activity with other TSF substrates. Five non-Pro1 were selected randomly for kinetic [using phenylenolpyruvate (PP) and 2-hydroxymuconate...

10.1021/acs.biochem.4c00338 article EN Biochemistry 2025-02-06

Abstract Pancreatic ductal adenocarcinoma (PDAC) carries an extremely poor prognosis, in part resulting from cellular heterogeneity that supports overall tumorigenicity. Cancer associated fibroblasts (CAF) are key determinants of PDAC biology and response to systemic therapy. While CAF subtypes have been defined, the effects patient-specific plasticity on tumor cell behavior remain unclear. Here, multi-omics was used characterize microenvironment (TME) tumors patients undergoing...

10.1101/2025.01.07.631784 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2025-01-08

In Gram‐negative septic shock, human monocytes synthesize and express on their cytoplasmic membrane tissue factor (TF), a potent activator of the coagulation cascades. The role TF in triggering disseminated intravascular (DIC) these patients appears to be clear. We report suppressive effect interleukin‐10 (IL‐10) endotoxin‐induced activity antigen levels, expression mRNA levels monocytes. These results emphasize potential therapeutic value this cytokine condition still associated with high...

10.1016/0014-5793(93)81693-t article EN FEBS Letters 1993-11-08

Tissue factor (TF) is a transmembrane receptor which, in association with factors VII and VIIa, activates IX X, thereby activating the coagulation protease cascades. In response to bacterial lipopolysaccharide (LPS) monocytes transcribe, synthesize express TF on their surface. We investigated whether LPS-induced human mediated by protein kinase C (PKC) activation. The PKC agonists phorbol 12-myristate 13-acetate (PMA) 12, 13 dibutyrate (PdBu) were both potent inducers of monocytes, whereas 4...

10.1055/s-0038-1649673 article EN Thrombosis and Haemostasis 1993-01-01

Fibrin deposition is an integral feature of the inflammatory response. In response to C‐reactive protein (CRP), acute‐phase reactant, blood monocytes synthesize and express tissue factor (TF), main initiator coagulation. We report inhibitory effect interleukin 10 (IL‐10) that pentoxifylline, a methyl xanthine derivative, on monocyte expression TF activity, mRNA in CRP. These agents may be use diseases where TF‐induced prothrombotic state detrimental.

10.1016/0014-5793(94)01236-9 article EN FEBS Letters 1994-12-14

Tissue factor (TF) is a transmembrane glycoprotein which assembles with VIIa on cell surfaces to form proteolytically active cofactor-enzyme complex; the TF/VIIa complex initiates coagulation protease cascade. In response bacterial lipopolysaccharide (LPS) and phorbol-12 myristate 13-acetate (PMA), monocytes synthesize express TF their surface. However, mechanisms by LPS PMA activate synthesis human blood are not fully understood. As it has been established that protein tyrosine kinase (PTK)...

10.1055/s-0038-1653790 article EN Thrombosis and Haemostasis 1995-01-01

Abstract Introduction: Pancreatic ductal adenocarcinoma (PDAC) is a heterogeneous tumor comprised of epithelial tumor, endothelial, immune, and importantly, cancer associated fibroblasts (CAFs) cells. CAFs drive complex microenvironment (TME) through mechanisms intratumoral interactions that are incompletely understood. It’s crucial to account for the role in modern ex-vivo systems as regulators both promoting restraining growth, providing growth factor support, reprogramming immune cells,...

10.1158/1538-7445.panca2023-a042 article EN Cancer Research 2024-01-16

Abstract Introduction: A complex immunosuppressive tumor microenvironment (TME) is a distinctive feature of pancreatic ductal adenocarcinoma (PDAC). The TME consists an admixture cell types including epithelial, endothelial, immune cells both myeloid and lymphoid origin, cancer-associated fibroblasts (CAFs). traditionally defined subtypes PDAC include classical, associated with the retention epithelial markers better prognosis, basal, which characterized by quasi-mesenchymal phenotype poorer...

10.1158/1538-7445.pancreatic24-a032 article EN Cancer Research 2024-09-15

<div>Abstract<p>Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy characterized by immunosuppressive tumor microenvironment enriched with cancer-associated fibroblasts (CAF). This study used a convergence approach to identify cell and CAF interactions through the integration of single-cell data from human tumors organoid coculture experiments. Analysis comprehensive atlas PDAC RNA sequencing indicated that density associated increased inflammation...

10.1158/0008-5472.c.7213937.v1 preprint EN 2024-05-02

<div>Abstract<p>Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy characterized by immunosuppressive tumor microenvironment enriched with cancer-associated fibroblasts (CAF). This study used a convergence approach to identify cell and CAF interactions through the integration of single-cell data from human tumors organoid coculture experiments. Analysis comprehensive atlas PDAC RNA sequencing indicated that density associated increased inflammation...

10.1158/0008-5472.c.7213937 preprint EN 2024-05-02
Coming Soon ...